Prospective Multicenter Phase II Study of Gemcitabine Plus Platinum Salt for Metastatic Collecting Duct Carcinoma: Results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) Study-Reference-Cited by-同舟云学术

Prospective Multicenter Phase II Study of Gemcitabine Plus Platinum Salt for Metastatic Collecting Duct Carcinoma: Results of a GETUG (Groupe d’Etudes des Tumeurs Uro-Génitales) Study

Published:2007-05 Issue:5 Volume:177 Page:1698-1702
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Oudard Stéphane¹²,Banu Eugeniu¹,Vieillefond Annick³,Fournier Laure⁴,Priou Franck⁵,Medioni Jacques¹,Banu Adela¹,Duclos Brigitte⁶,Rolland Fréderic⁷,Escudier Bernard⁸,Arakelyan Nina¹,Culine Stéphane⁹

Affiliation:

1. Medical Oncology Department, Georges Pompidou European Hospital, Paris, France

2. René Descartes University, Paris, France

3. Pathology Department, Cochin Hospital, Paris, France

4. Radiology Department, Georges Pompidou European Hospital, Paris, France

5. Oncology Department, La Roche sur Yon Hospital, La Roche sur Yon, France

6. Strasbourg University Hospital, Strasbourg, France

7. René Gauducheau Center, Nantes, France

8. Gustave Roussy Cancer Centre, Villejuif, France

9. Val d’Aurelle Center, Montpellier, France

Publisher

Ovid Technologies (Wolters Kluwer Health)